CA2088195A1 - Cholecystokinin antagonists, their preparation and therapeutic use - Google Patents
Cholecystokinin antagonists, their preparation and therapeutic useInfo
- Publication number
- CA2088195A1 CA2088195A1 CA002088195A CA2088195A CA2088195A1 CA 2088195 A1 CA2088195 A1 CA 2088195A1 CA 002088195 A CA002088195 A CA 002088195A CA 2088195 A CA2088195 A CA 2088195A CA 2088195 A1 CA2088195 A1 CA 2088195A1
- Authority
- CA
- Canada
- Prior art keywords
- dec
- tricyclo
- indol
- methyl
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/595—Gastrins; Cholecystokinins [CCK]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- C07K5/06156—Dipeptides with the first amino acid being heterocyclic and Trp-amino acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US57662890A | 1990-08-31 | 1990-08-31 | |
US576,628 | 1990-08-31 | ||
US72665591A | 1991-07-12 | 1991-07-12 | |
US726,655 | 1991-07-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2088195A1 true CA2088195A1 (en) | 1992-03-01 |
Family
ID=27077012
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002088195A Abandoned CA2088195A1 (en) | 1990-08-31 | 1991-08-29 | Cholecystokinin antagonists, their preparation and therapeutic use |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0547178A4 (ja) |
JP (1) | JPH06502627A (ja) |
KR (1) | KR100222634B1 (ja) |
CA (1) | CA2088195A1 (ja) |
IE (1) | IE67290B1 (ja) |
NO (1) | NO312298B1 (ja) |
NZ (1) | NZ239595A (ja) |
PT (1) | PT98842B (ja) |
WO (1) | WO1992004045A1 (ja) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5217957A (en) * | 1991-08-20 | 1993-06-08 | Warner-Lambert Company | Cholecystokinin antagonists useful for treating depression |
US5380872A (en) * | 1992-07-14 | 1995-01-10 | Glaxo Inc. | Modulators of cholecystokinin |
WO1994018229A1 (en) * | 1993-02-03 | 1994-08-18 | Fisons Corporation | 1,2,4-triazinone derivatives and their use in therapy |
GB9304500D0 (en) * | 1993-03-05 | 1993-04-21 | Glaxo Spa | Heterocyclic compounds |
ATE311383T1 (de) | 1996-08-22 | 2005-12-15 | Warner Lambert Co | Nicht-peptidische bombesin rezeptor antagonisten |
US6645968B2 (en) | 1999-08-03 | 2003-11-11 | Abbott Laboratories | Potassium channel openers |
US6846836B2 (en) | 2003-04-18 | 2005-01-25 | Bristol-Myers Squibb Company | N-substituted phenylurea inhibitors of mitochondrial F1F0 ATP hydrolase |
WO2005077344A2 (en) | 2003-08-29 | 2005-08-25 | The Brigham And Women's Hospital, Inc. | Hydantoin derivatives as inhibitors of cellular necrosis |
US8604244B2 (en) | 2010-07-02 | 2013-12-10 | Reviva Pharmaceuticals, Inc. | Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives |
EP2066329B1 (en) * | 2006-09-15 | 2017-09-06 | Reviva Pharmaceuticals, Inc. | Synthesis, methods of using, and compositions of cyclobutylmethylamines |
AU2009329879A1 (en) | 2008-12-23 | 2011-08-11 | President And Fellows Of Harvard College | Small molecule inhibitors of necroptosis |
GB0919194D0 (en) | 2009-11-02 | 2009-12-16 | Lytix Biopharma As | Compounds |
US9725452B2 (en) | 2013-03-15 | 2017-08-08 | Presidents And Fellows Of Harvard College | Substituted indoles and pyrroles as RIP kinase inhibitors |
EP3229807A4 (en) | 2014-12-11 | 2018-10-17 | President and Fellows of Harvard College | Inhibitors of cellular necrosis and related methods |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4757151A (en) * | 1985-11-14 | 1988-07-12 | Warner-Lambert Company | 2-substituted-[2-substituted-amino]-N-arylalkyl-3-[indol-3-yl] |
CA1291031C (en) * | 1985-12-23 | 1991-10-22 | Nikolaas C.J. De Jaeger | Method for the detection of specific binding agents and their correspondingbindable substances |
US4814463A (en) * | 1985-12-31 | 1989-03-21 | Biomeasure, Inc. | CCK antagonists |
FR2606963B1 (fr) * | 1986-11-14 | 1989-01-13 | Cit Alcatel | Boitier de repeteur sous-marin |
EP0336356A3 (en) * | 1988-04-05 | 1991-09-25 | Abbott Laboratories | Derivatives of tryptophan as cck antagonists |
NZ234264A (en) * | 1989-06-29 | 1993-05-26 | Warner Lambert Co | N-substituted cycloalkyl and polycycloalkyl alpha-substituted trp-phe- and phenethylamine derivatives, and pharmaceutical compositions |
US5244915A (en) * | 1990-08-31 | 1993-09-14 | Warner-Lambert Company | Amico acid derivatives cyclized at the c-terminal |
-
1991
- 1991-08-29 JP JP3517185A patent/JPH06502627A/ja active Pending
- 1991-08-29 WO PCT/US1991/006180 patent/WO1992004045A1/en not_active Application Discontinuation
- 1991-08-29 NZ NZ239595A patent/NZ239595A/en unknown
- 1991-08-29 KR KR1019930700601A patent/KR100222634B1/ko not_active IP Right Cessation
- 1991-08-29 EP EP19910918880 patent/EP0547178A4/en not_active Withdrawn
- 1991-08-29 CA CA002088195A patent/CA2088195A1/en not_active Abandoned
- 1991-08-30 IE IE307791A patent/IE67290B1/en not_active IP Right Cessation
- 1991-08-30 PT PT98842A patent/PT98842B/pt not_active IP Right Cessation
-
1993
- 1993-02-26 NO NO19930709A patent/NO312298B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
IE913077A1 (en) | 1992-03-11 |
NO930709L (no) | 1993-04-15 |
AU8749291A (en) | 1992-03-30 |
IE67290B1 (en) | 1996-03-20 |
NO312298B1 (no) | 2002-04-22 |
AU651390B2 (en) | 1994-07-21 |
NZ239595A (en) | 1994-06-27 |
JPH06502627A (ja) | 1994-03-24 |
WO1992004045A1 (en) | 1992-03-19 |
KR100222634B1 (ko) | 1999-10-01 |
EP0547178A4 (en) | 1994-07-06 |
PT98842B (pt) | 1999-01-29 |
PT98842A (pt) | 1992-08-31 |
NO930709D0 (no) | 1993-02-26 |
KR930703349A (ko) | 1993-11-29 |
EP0547178A1 (en) | 1993-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2344707C (en) | N-substituted cycloalkyl and polycycloalkyl alpha-substituted trp-phe- and phenethylamine derivatives | |
AU658377B2 (en) | Alpha-substituted tryptophane dipeptoid derivatives | |
CA2088195A1 (en) | Cholecystokinin antagonists, their preparation and therapeutic use | |
AU649077B2 (en) | Pro-drugs for CCK antagonists | |
US5846942A (en) | Cholecystokinin antagonists, their preparation and therapeutic use | |
US5278316A (en) | N-substituted cycloalkyl and polycycloalkyl alpha-substituted Trp-Phe- and phenethylamine derivatives | |
US5574013A (en) | N-substituted cycloalkyl and polycycloalkyl alpha-substituted Trp derivatives | |
US5340825A (en) | Pro drugs for CCK antagonists | |
WO1992004348A1 (en) | N-substituted cycloalkyl and polycycloakyl polyhydro-β-carboline-phenylalanine-and phenethylamine derivatives | |
AU651390C (en) | Novel cholecystokinin antagonists, their preparation and therapeutic use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |